D'Hondt; Erik
Patent Applications and Registrations
Patent applications and USPTO patent grants for D'Hondt; Erik.The latest application filed is for "stabilized chimeric synthetic proteins and therapeutic uses thereof".
- D'Hondt; Erik - Bazel BE
- D'Hondt; Erik - Merelbeke BE
- D'Hondt; Erik - Ottenburg BE
- D'Hondt, Erik - Huldenberg BE
- D'hondt, Erik - Kruibeke BE
| Patent | Date |
|---|---|
| Stabilized Chimeric Synthetic Proteins And Therapeutic Uses Thereof App 20220305105 - D'Hondt; Erik ; et al. | 2022-09-29 |
| Self-assembling synthetic proteins Grant 11,419,923 - Charlton , et al. August 23, 2 | 2022-08-23 |
| Recombinant Proteins And Their Therapeutic Uses App 20220153798 - Charlton; Keith Alan ; et al. | 2022-05-19 |
| Methods And Compositions For Inhibition Of Egf/egfr Pathway In Combination With Tyrosine Kinase Inhibitors App 20220041704 - D'Hondt; Erik ; et al. | 2022-02-10 |
| Recombinant proteins and their therapeutic uses Grant 11,198,716 - Charlton , et al. December 14, 2 | 2021-12-14 |
| Synthetic Proteins And Therapeutic Uses Thereof App 20210009716 - D'Hondt; Erik ; et al. | 2021-01-14 |
| Self-assembling Synthetic Proteins App 20200297827 - Charlton; Keith Alan ; et al. | 2020-09-24 |
| Epidermal growth factor fusion proteins with mutant cholera toxin B subunits Grant 10,736,948 - Charlton , et al. A | 2020-08-11 |
| Methods And Compositions For Inhibition Of Egf/egfr Pathway In Combination With Anaplastic Lymphoma Kinase Inhibitors App 20200046690 - D'Hondt; Erik ; et al. | 2020-02-13 |
| Methods And Compositions For Inhibition Of Egf/egfr Pathway In Combination With Tyrosine Kinase Inhibitors App 20190358320 - D'Hondt; Erik ; et al. | 2019-11-28 |
| Recombinant Proteins And Their Therapeutic Uses App 20180162917 - Charlton; Keith Alan ; et al. | 2018-06-14 |
| Recombinant proteins and their therapeutic uses Grant 9,902,760 - Charlton , et al. February 27, 2 | 2018-02-27 |
| Methods And Compositions For Inhibition Of Egf/egfr Pathway In Combination With Tyrosine Kinase Inhibitors App 20160333087 - D'Hondt; Erik ; et al. | 2016-11-17 |
| Recombinant Proteins And Their Therapeutic Uses App 20160207972 - Charlton; Keith Alan ; et al. | 2016-07-21 |
| Self-assembling Synthetic Proteins App 20160095910 - Charlton; Keith Alan ; et al. | 2016-04-07 |
| Recombinant Proteins And Their Therapeutic Uses App 20140248302 - Charlton; Keith Alan ; et al. | 2014-09-04 |
| Composition Grant 7,238,349 - D'Hondt , et al. July 3, 2 | 2007-07-03 |
| Influenza vaccine App 20070141078 - D'Hondt; Erik ; et al. | 2007-06-21 |
| Hepatitis A vaccines Grant 6,991,929 - D'Hondt January 31, 2 | 2006-01-31 |
| Hepatitis A vaccines App 20050112144 - D'Hondt, Erik | 2005-05-26 |
| Salmonella typhi vaccine compositions App 20040213806 - Demil, Pascale ; et al. | 2004-10-28 |
| HCV compositions App 20040151735 - Maertens, Geert ; et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 